IMMvention Therapeutics

Imara

This biopharmaceutical company develops oral small-molecule therapies to treat patients with rare genetic blood disorders, including sickle cell disease and beta thalassemia.

Forma Therapeutics

This company develops medicines for patients with sickle cell disease and rare blood disorders.

Kamau Therapeutics

This company develops clinical-stage gene correction therapies using targeted DNA integration to treat patients with sickle cell disease and other genetic conditions.

Forma

This company develops small molecule therapies for patients with sickle cell disease and cancer.

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Global Blood Therapeutics

This biopharmaceutical company develops and manufactures oral medicines to treat sickle cell disease for patients and healthcare providers.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.